2O Health-related Quality of Life (hrqol) with First-Line (1L) Nivolumab (NIVO) Plus Ipilimumab (IPI) Vs Chemotherapy (chemo) in Patients (pts) with Microsatellite Instability-High (Msi-H)/mismatch Repair-Deficient (dmmr) Metastatic Colorectal Cancer (mcrc): CheckMate 8HW

S. Lonardi, T. André, D. Arnold, R. Garcia-Carbonero,M. Chalabi,M.E. Elez Fernandez, H.J. Lenz, L.H. Jensen, R. Joshi,J.M.L. Roodhart, T. Yoshino, M. Dixon,S.I. Blum, J. Sims, R. Lawrance, F. Taylor, T. Chen, E. Cela, L. Jin,E. Van Cutsem

Annals of Oncology（2024）

引用 0|浏览2

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要